Cargando…
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
Prostate is an immune-competent organ normally populated by inflammatory cells. Prostatic inflammation origin can be multi-factorial and there are some emerging evidences on its possible role as a factor involved in prostate cancer (PC) pathogenesis and progression. This review critically analyzes t...
Autores principales: | Sciarra, Alessandro, Gentilucci, Alessandro, Salciccia, Stefano, Pierella, Federico, Del Bianco, Flavio, Gentile, Vincenzo, Silvestri, Ida, Cattarino, Susanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123292/ https://www.ncbi.nlm.nih.gov/pubmed/27924136 http://dx.doi.org/10.1186/s12950-016-0143-2 |
Ejemplares similares
-
A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer
por: Sciarra, Alessandro, et al.
Publicado: (2016) -
Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma
por: Silvestri, Ida, et al.
Publicado: (2013) -
Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer: A critical review
por: Sciarra, Alessandro, et al.
Publicado: (2019) -
Laparoscopic versus open radical prostatectomy in high prostate volume cases: impact on oncological and functional results
por: Alessandro, Sciarra, et al.
Publicado: (2016) -
Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients?
por: Sciarra, Alessandro, et al.
Publicado: (2023)